Cited by 76Gastrointestinal motility and disordersPsychosomatic Disorders and Their TreatmentsGastroesophageal reflux and treatments

Use of psychopharmacological agents for functional gastrointestinal disorders.

Open access
Clouse, R E, Lustman, P J·2005·Gut

Abstract

In 1990 we asked clinicians attending a symposium during the annual meeting of the American Gastroenterological Association how many were using psychopharmacological agents, specifically antidepressants, to treat functional gastrointestinal disorders.1 Very few raised their hands. Over the subsequent 15 years, these agents increasingly have become used in the management of functional gastrointestinal symptoms, despite a limited amount of scientific information supporting this practice. It is now estimated that at least 1 in 8 patients with irritable bowel syndrome (IBS) is offered an antidepressant.2,3 Nearly every comprehensive current review of management strategies for IBS and other mainstream functional gastrointestinal disorders mentions their use, and prescribing among gastroenterologists has become commonplace.3–10 In parallel with this change, primary care physicians have become sufficiently comfortable in using antidepressants for treating not only anxiety and depression but also a host of somatic symptoms and syndromes that their use has nearly tripled in the past decade.11 Enhanced appreciation for the relative importance of central mechanisms (for example, signal processing alterations) in many if not most patients with IBS and other painful functional gastrointestinal disorders is an important factor responsible for prescribing shifts among gastroenterologists—more so than a new or improved understanding of the relationship of symptoms to anxiety or depression.8 The composite body of investigation over the past 15 years involving visceral stimulation, brain imaging, multidimensional clinical studies, and treatment trials designed to answer mechanistic questions has led us closer to understanding the pathways by which psychopharmacological agents may interrupt the symptomatic process in these common gastrointestinal disorders. Complemented by clinical observations, improved recommendations for their use have evolved.6,12 This review describes the types of psychopharmacological agents used in functional gastrointestinal disorders, new models for their potential benefits, a summary of the reported efficacy, and practical aspects …

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gut.2004.048884

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 4

  1. Jackson JL, O'Malley PG, Tomkins G, et al. Treatment of functional gastrointestinal disorders with antidepressant medication: a meta-analysis. Am J Med 2000;108:65-72.
  2. O'Malley PG, Jackson JL, Tomkins GE, et al. Efficacy of antidepressants for physical symptoms: a critical review. J Gen Intern Med 1999;14(suppl 2):60.
  3. McQuay HJ, Moore RA. Antidepressants and chronic pain: effective analgesia in neuropathic pain and other syndromes. BMJ 1997;314:763-4.
  4. Freedland KE, Carney RM, Lustman PJ. The impact of psychiatric disorders on medical illness. In: Rubin EH, Zorumski CF, eds. Adult psychiatry, 2nd edn. Oxford: Blackwell Publishing, 2005 (in press).

Cited by

Sorted by citations

Authors
Clouse, R. E., & Lustman, P. J.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Clouse, R E
Venue
Gut
Publisher
BMJ
Published
2005-08-11
Volume
54
Issue
9
Pages
1332-1341
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2008866516
Cited by
76
References
89
Citations by year
2025: 1 · 2024: 1 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 1 · 2014: 5 · 2013: 3 · 2012: 6
FWCI
1.09
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
Keywords
antidepressants, psychopharmacological agents, functional gastrointestinal disorders, irritable bowel syndrome, visceral stimulation, neuroimaging, prescribing patterns, somatic symptoms
MeSH terms
Antidepressive Agents, Gastrointestinal Diseases, Humans, Psychophysiologic Disorders, Anti-Anxiety Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review